| # | Drug | Count |
|---|---|---|
| 0 | LENALIDOMIDE | 203 |
| 1 | OXALIPLATIN | 166 |
| 2 | FLUOROURACIL | 161 |
| 3 | FLUOROURACIL CREAM, 0.5% | 160 |
| 4 | METHOTREXATE SODIUM | 140 |
| 5 | BEVACIZUMAB | 137 |
| 6 | DEXAMETHASONE | 137 |
| 7 | DEXAMETHASONE 1.5 MG | 137 |
| 8 | METHOTREXATE | 119 |
| 9 | ADALIMUMAB | 114 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PANITUMUMAB | 113 | 0.0070 |
| 1 | BARICITINIB | 14 | 0.0046 |
| 2 | FRUQUINTINIB | 18 | 0.0046 |
| 3 | AMOXICILLIN AND CLAVULANATE POTASSIUM | 19 | 0.0042 |
| 4 | CALCIUM FOLINATE | 16 | 0.0034 |
| 5 | CHLORAMBUCIL | 12 | 0.0031 |
| 6 | DROPERIDOL | 5 | 0.0030 |
| 7 | REGORAFENIB | 29 | 0.0025 |
| 8 | OXALIPLATIN | 166 | 0.0022 |
| 9 | FLUOROURACIL CREAM, 0.5% | 160 | 0.0021 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 340 |
| 1 | Nucleoside Metabolic Inhibitor [EPC] | 230 |
| 2 | Thalidomide Analog [EPC] | 212 |
| 3 | Platinum-based Drug [EPC] | 182 |
| 4 | Tumor Necrosis Factor Blocker [EPC] | 180 |
| 5 | Nonsteroidal Anti-inflammatory Drug [EPC] | 165 |
| 6 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 149 |
| 7 | Epidermal Growth Factor Receptor Antagonist [EPC] | 138 |
| 8 | Proton Pump Inhibitor [EPC] | 124 |
| 9 | Folate Analog Metabolic Inhibitor [EPC] | 119 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD38-directed Cytolytic Antibody [EPC] | 26 | 0.0044 |
| 1 | Epidermal Growth Factor Receptor Antagonist [EPC] | 138 | 0.0029 |
| 2 | Interleukin-5 Antagonist [EPC] | 1 | 0.0015 |
| 3 | Provitamin D2 Compound [EPC] | 43 | 0.0014 |
| 4 | Humanized Monoclonal Antibody Fragment [EPC] | 2 | 0.0014 |
| 5 | Gonadotropin [EPC] | 3 | 0.0014 |
| 6 | Integrin Receptor Antagonist [EPC] | 105 | 0.0012 |
| 7 | Prostacycline [EPC] | 1 | 0.0011 |
| 8 | Interleukin-17A Antagonist [EPC] | 37 | 0.0010 |
| 9 | Guanylate Cyclase-C Agonist [EPC] | 2 | 0.0010 |